Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PF-431396 |
| Trade Name | |
| Synonyms | PF431396|PF 431396 |
| Drug Descriptions |
PF-431396 is a dual inhibitor of FAK and PTK2B (PYK2), which may result in inhibition of cell growth (PMID: 27793840, PMID: 29303405). |
| DrugClasses | FAK inhibitor 16 |
| CAS Registry Number | 717906-29-1 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Erlotinib + PF-431396 | Erlotinib PF-431396 | 0 | 0 |
| Gefitinib + PF-431396 | Gefitinib PF-431396 | 0 | 0 |
| PF-431396 | PF-431396 | 0 | 0 |